Opthea Presents at JMP Securities Life Sciences Conference -…
MELBOURNE, Australia, May 8, 2023 (GLOBE NEWSWIRE) — Opthea Limited optopt)), a clinical-stage biopharmaceutical company developing novel therapies to treat common and progressive retinal diseases,